Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer.
about
The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell CarcinomaCutaneous Melanoma in AsiansComparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.Targeting CD137 enhances the efficacy of cetuximab.Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.Proteomic investigation of the sinulariolide-treated melanoma cells A375: effects on the cell apoptosis through mitochondrial-related pathway and activation of caspase cascademiR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.Induction of apoptosis by 11-dehydrosinulariolide via mitochondrial dysregulation and ER stress pathways in human melanoma cellsComparison of vascular leak syndrome in mice treated with IL21 or IL2Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapyEnhancing adoptive T cell immunotherapy with microRNA therapeutics.Spaceflight effects on T lymphocyte distribution, function and gene expression.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma.Bladder metastasis of malignant melanoma: a case report and review of literature.Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity.Adoptive T cell therapy: An overview of obstacles and opportunities.Proteomic investigation of anti-tumor activities exerted by sinularin against A2058 melanoma cells.Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapyCD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity.The Effect of Bornyl cis-4-Hydroxycinnamate on Melanoma Cell Apoptosis Is Associated with Mitochondrial Dysfunction and Endoplasmic Reticulum Stress.Haliotis discus discus Sialic Acid-Binding Lectin Reduces the Oncolytic Vaccinia Virus Induced Toxicity in a Glioblastoma Mouse Model.
P2860
Q26777889-A8EC7E80-EEDA-402F-91BB-0F5C5AE0428BQ28078576-F69E3B02-02E4-4BA4-A303-05D3012AAA48Q33407216-8659B7F9-A3E9-492E-932F-1BF0305E4684Q33872482-12A7A76A-A96E-45A4-A154-73EC4BBFA281Q34682072-29BFBA0F-6F2C-4829-86A5-61BDEAF57BDCQ34861389-3DD9AEE1-9AE3-4DCF-9C1A-31694259FF55Q34985536-2371FB67-A019-44C8-9532-B4B1ABF00F4BQ35780315-9E0D849B-4F0A-4E4B-837F-D6DC7E5B60D4Q35812429-64CC7E74-4F3E-469D-979A-59A0E8C1A487Q36248410-959FED77-BA85-4269-8429-97E71CE34C54Q36595426-82440AF4-030F-4343-A6DB-12C12D0FEC98Q36696647-56A39BA5-1AC5-4875-8B8F-590F2E9D4A11Q36889204-2283E3A1-9895-4B91-BB8C-F1D287C04E29Q37086204-C1591E08-FF9E-4579-BE3E-DA77FB5739E5Q37414808-5506C263-38A9-4157-86B1-FD173BF29B97Q37806166-4E788DB9-D533-4501-AA92-F6EB5F17855FQ38429444-EC1BE727-0B1D-4018-9F13-7CC15DE20DA7Q39329596-529997B2-EF2E-438C-B958-5D47230D813AQ39357652-150F5737-31FE-4EED-8271-9C1A880DC3DAQ41239757-30B117CD-107C-413B-9A57-9F77781413EDQ41859070-EDCC1D23-AEA7-4B2C-BA6D-7D78ED972BB4Q49722865-B8E05FD8-7C5C-4337-BAD3-044722F61871Q54111816-169AA1A3-CAF8-48FD-BB22-0C06B3AB763FQ54980119-1F67147A-E880-4F2D-BD6E-789A9F2B5DD2
P2860
Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@en
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@nl
type
label
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@en
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@nl
prefLabel
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@en
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@nl
P2093
P1476
Toxicity and activity of a twi ...... metastatic renal cell cancer.
@en
P2093
Deepak Narayan
Harold Tara
Harriet Kluger
Leonard Farber
Nicolas Acquavella
Stephan Ariyan
William Kelly
P304
P356
10.1097/CJI.0B013E318177A4BA
P50
P577
2008-07-01T00:00:00Z